ROYAL BANK OF CANADA - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 152 filers reported holding ANI PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 9.51 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$164,000
+74.5%
2,819
+61.2%
0.00%
Q2 2023$94,000
+161.1%
1,749
+93.3%
0.00%
Q1 2023$36,000
-57.1%
905
-56.9%
0.00%
Q4 2022$84,000
+663.6%
2,098
+506.4%
0.00%
Q3 2022$11,000
+37.5%
346
+31.6%
0.00%
Q2 2022$8,000
-66.7%
263
-69.6%
0.00%
Q1 2022$24,000
-76.0%
864
-60.1%
0.00%
Q4 2021$100,000
+185.7%
2,164
+101.9%
0.00%
Q3 2021$35,000
+16.7%
1,072
+24.4%
0.00%
Q2 2021$30,000
+50.0%
862
+53.4%
0.00%
Q1 2021$20,000
-82.0%
562
-85.3%
0.00%
Q4 2020$111,000
+2.8%
3,817
-0.2%
0.00%
Q3 2020$108,000
-10.7%
3,823
+1.8%
0.00%
Q2 2020$121,000
-20.4%
3,755
+0.8%
0.00%
Q1 2020$152,000
-11.1%
3,726
+34.0%
0.00%
Q4 2019$171,000
-12.8%
2,781
+3.2%
0.00%
Q3 2019$196,000
-13.7%
2,696
-2.5%
0.00%
Q2 2019$227,000
+233.8%
2,765
+186.8%
0.00%
Q1 2019$68,000
+70.0%
964
+8.2%
0.00%
Q4 2018$40,000
-43.7%
891
-28.8%
0.00%
Q3 2018$71,000
+195.8%
1,251
+253.4%
0.00%
Q2 2018$24,000
+500.0%
354
+436.4%
0.00%
Q1 2018$4,000
-50.0%
66
-45.9%
0.00%
Q4 2017$8,000
-76.5%
122
-81.1%
0.00%
Q3 2017$34,000
+580.0%
644
+631.8%
0.00%
Q2 2017$5,000
-50.0%
88
-58.7%
0.00%
Q1 2017$10,000
-80.0%
213
-74.2%
0.00%
Q4 2016$50,000
+11.1%
826
+21.3%
0.00%
Q3 2016$45,000
+275.0%
681
+208.1%
0.00%
Q2 2016$12,000
+71.4%
2210.0%0.00%
Q1 2016$7,000
-53.3%
221
-35.0%
0.00%
Q4 2015$15,000
-81.7%
340
-83.6%
0.00%
Q3 2015$82,000
+485.7%
2,078
+840.3%
0.00%
Q2 2015$14,0000.0%2210.0%0.00%
Q1 2015$14,000
-51.7%
221
-57.6%
0.00%
Q4 2014$29,000
+480.0%
521
+168.6%
0.00%
Q3 2014$5,000
-87.8%
194
-83.8%
0.00%
Q2 2014$41,000
+583.3%
1,194
+512.3%
0.00%
Q1 2014$6,000
+100.0%
195
+14.7%
0.00%
Q4 2013$3,000
+50.0%
170
+1.8%
0.00%
Q3 2013$2,0001670.00%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
AIGH Capital Management LLC 272,801$15,838,8267.50%
Global Alpha Capital Management Ltd. 525,528$30,512,1563.06%
Rubric Capital Management LP 847,011$49,177,4591.84%
Ranger Investment Management 426,848$24,782,7951.64%
Parkman Healthcare Partners LLC 111,802$6,491,2241.19%
MARATHON CAPITAL MANAGEMENT 71,670$4,161,1601.05%
Mesirow Financial Investment Management, Inc. 3,862$224,2280.98%
Deep Track Capital, LP 400,000$23,224,0000.90%
1492 Capital Management LLC 18,178$1,055,4150.68%
Phocas Financial Corp. 75,213$4,367,0000.64%
View complete list of ANI PHARMACEUTICALS INC shareholders